Literature DB >> 23143804

[Transoral robotic surgery for head and neck tumors: a series of 17 patients].

S Mattheis1, M Mandapathil, N Rothmeier, S Lang, N Dominas, T K Hoffmann.   

Abstract

BACKGROUND: Within the last years transoral robotic surgery (TORS) has gained importance in the resection of head and neck tumors, especially in North America. In contrast only few groups in Germany have studied this system so far. In respect to potential future developments in surgical robotic systems it seems reasonable to deal with this system.
MATERIAL AND METHODS: 17 patients with tumors of the oropharynx, the base of tongue or the supraglottic area were treated with TORS in our clinic, between May 2011 and June 2012. In a prospective study we analyzed the exposure, visualization and resectability of these tumors using the da Vinci-system. In addition, set up and operation time, as well as costs were evaluated.
RESULTS: All neoplasms of the oropharynx (n=9) and the tongue base (n=5) could be well exposed, visualized and resected. In the supraglottic area (n=3) 2 tumors could not be properly exposed and therefore resection was converted to a transoral microscopic laser approach. Resection with the cautery spatula tip or the Tm:YAG-laser fibre caused wide coagulation zones, but resulted in good hemostasis. The costs for the medical equipment and the leasing rate were 6280 € per case at our institution.
CONCLUSION: Tumors of the tongue base and oropharynx could be easily visualized with help of the da Vinci-system. The resection of supraglottic tumors can be challenging, due to the arrangement of the robotic-arms and the narrow anatomic conditions. Despite its high costs, the da Vinci-system is a potentially interesting supplementation to existing surgical techniques. © Georg Thieme Verlag KG Stuttgart · New York.

Entities:  

Mesh:

Year:  2012        PMID: 23143804     DOI: 10.1055/s-0032-1327663

Source DB:  PubMed          Journal:  Laryngorhinootologie        ISSN: 0935-8943            Impact factor:   1.057


  8 in total

1.  [Advances in transoral robotic surgery].

Authors:  S Mattheis; B Kansy; P Haßkamp; L Holtmann; S Lang
Journal:  HNO       Date:  2015-11       Impact factor: 1.284

2.  Comparative analysis of resection tools suited for transoral robot-assisted surgery.

Authors:  Thomas K Hoffmann; Patrick J Schuler; Agnes Bankfalvi; Jens Greve; Lukas Heusgen; Stephan Lang; Stefan Mattheis
Journal:  Eur Arch Otorhinolaryngol       Date:  2013-07-12       Impact factor: 2.503

3.  First use of a new retractor in transoral robotic surgery (TORS).

Authors:  P Hasskamp; S Lang; L Holtmann; B A Stuck; S Mattheis
Journal:  Eur Arch Otorhinolaryngol       Date:  2015-07-16       Impact factor: 2.503

Review 4.  [Robot-assisted surgery in the head and neck region].

Authors:  T K Hoffmann; D T Friedrich; P J Schuler
Journal:  HNO       Date:  2016-09       Impact factor: 1.284

Review 5.  [Robot-assisted head and neck surgery].

Authors:  P J Schuler; F Boehm; L R Schild; J Greve; T K Hoffmann
Journal:  HNO       Date:  2021-02       Impact factor: 1.284

6.  Application of a computer-assisted flexible endoscope system for transoral surgery of the hypopharynx and upper esophagus.

Authors:  Daniel T Friedrich; M O Scheithauer; J Greve; N Rotter; J Doescher; T K Hoffmann; P J Schuler
Journal:  Eur Arch Otorhinolaryngol       Date:  2017-02-24       Impact factor: 2.503

7.  The robotic-assisted extended "Sistrunk" approach for tumors of the upper aerodigestive tract with limited transoral access: First description of oncological and functional outcomes.

Authors:  Christian Simon; Avinash Beharry; Vinidh Paleri; Pascaline Dübi; Karma Lambercy; F Christopher Holsinger; Jelena Todic
Journal:  Head Neck       Date:  2022-06-02       Impact factor: 3.821

Review 8.  Current Advances in Robotics for Head and Neck Surgery-A Systematic Review.

Authors:  Felix Boehm; Rene Graesslin; Marie-Nicole Theodoraki; Leon Schild; Jens Greve; Thomas K Hoffmann; Patrick J Schuler
Journal:  Cancers (Basel)       Date:  2021-03-19       Impact factor: 6.639

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.